218 - Introduction to Cost-Effectiveness Analysis

نویسندگان

  • Emilie S. Powell
  • Brian W. Patterson
چکیده

CEA is becoming an increasingly important input into health policy decisions; however, the methodology does have limitations. CEA cannot incorporate all aspects of a decision, and the results are only as good as the data available to input into the analyses. Economic analyses such as CEA cannot capture every input necessary to make health care decisions and should not be reported as scientific fact, but models and their results may be reported as aids in decision making. An additional criticism of CEA is that although the economic models have become increasingly complex to better represent reality, they have also become increasingly opaque to the lay reader, thus making it difficult for those without a background in economics to personally interpret the results. Despite these limitations, CEA offers the benefit of adding perspective to difficult questions regarding treatment choices in the setting of limited resources. If emergency physicians are to act as decision makers in our changing practice environment, it is essential to have an understanding of the basic principles of CEA.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Cost-Effectiveness analysis of malaria diagnosis techniques in patients with suspected malaria in Hormozgan province- 2012

Introduction: Since ancient times Malaria in Iran has been considered as a serious health risk, especially in Hormozgan Province, as no other disease like Malaria has imposed irreparable financial and life losses to the country. Since saving costs in the healthcare sector comes as first priority in most countries, this study aims at launching a cost-effectiveness analysis on malaria diagnosis d...

متن کامل

Cost- Effectiveness Analysis of Infectious Waste Treatment Devices in Hospital

Introduction: Today, the infectious wastes of hospitals are considered as a public health problem. Considering the huge amounts of hazardous wastes and the disadvantages of incinerators, we need to investigate the non-combustible devices involved in biochemical treatment. This study was carried out with the aim of evaluating the cost-effectiveness of infectious wastes devices. Materials and Me...

متن کامل

Use of Cost-Effectiveness Data in Priority Setting Decisions: Experiences from the National Guidelines for Heart Diseases in Sweden

Background The inclusion of cost-effectiveness data, as a basis for priority setting rankings, is a distinguishing feature in the formulation of the Swedish national guidelines. Guidelines are generated with the direct intent to influence health policy and support decisions about the efficient allocation of scarce healthcare resources. Certain medical conditions may be given higher priority ran...

متن کامل

Economic Evaluation of Infliximab for Treatment of Refractory Ulcerative Colitis in Iran: Cost-Effectiveness Analysis

The aim of this study is to assess cost-effectiveness of infliximab, compared with conventional treatments in patients with moderate to severe Ulcerative Colitis (UC) in Iran. We developed an analytical decision model with a 5-year-time horizon to follow up 1000 hypothetical patients, in order to estimate treatment costs and outcomes. Hypothetical patients, were individuals with moderate to sev...

متن کامل

Cost-Effectiveness Analysis of Health Interventions: A Critical Review

Background and Aim: Economic evaluation of health interventions by comparing the relevant costs and benefits will result in optimum allocation of resources and increasing the effectiveness of the health system and, through improving equity and increasing accessibility to health services, will lead to increased effectiveness of the health system. The purpose of this study was to critically evalu...

متن کامل

Big costs for little gain in ovarian cancer.

The results of the GOG 218 (Gynecologic Oncology Group) study were reported in abstract form at the 46th Annual Meeting of the American Society of Clinical Oncology in June 2010. In this threearm randomized phase III study, women with advanced epithelial ovarian cancer (stage III or IV, after maximal attempt at surgical debulking) were assigned to treatment with paclitaxel plus carboplatin foll...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2013